A
Health Impact News subscriber in Europe ran the reports for each of the four COVID-19 shots we are including here. This subscriber has volunteered to do this, and it is a lot of work to tabulate each reaction with injuries and fatalities, since there is no place on the
EudraVigilance system we have found that tabulates all the results.
Since we have started publishing this, others from Europe have also calculated the numbers and confirmed the totals.* Here is the summary data through May 8, 2021.
Total reactions for the experimental mRNA vaccine Tozinameran (code BNT162b2,Comirnaty) from BioNTech/ Pfizer: 5,368 deaths and 170,528 injuries to 08/05/2021
- 12,435 Blood and lymphatic system disorders incl. 54 deaths
- 8,551 Cardiac disorders incl. 636 deaths
- 62 Congenital, familial and genetic disorders incl. 4 deaths
- 4,828 Ear and labyrinth disorders incl. 3 deaths
- 153 Endocrine disorders
- 5,413 Eye disorders incl. 9 deaths
- 37,167 Gastrointestinal disorders incl. 270 deaths
- 115,627General disorders and administration site conditions incl. 1719 deaths
- 279 Hepatobiliary disorders incl. 24 deaths
- 4,047 Immune system disorders incl. 25 deaths
- 12,099 Infections and infestations incl. 589 deaths
- 4,142 Injury, poisoning and procedural complications incl. 72 deaths
- 8,904 Investigations incl. 196 deaths
- 2,961 Metabolism and nutrition disorders incl. 109 deaths
- 59,217 Musculoskeletal and connective tissue disorders incl. 58 deaths
- 194 Neoplasms benign, malignant and unspecified (incl cysts and polyps) incl. 11 deaths
- 73,4 Nervous system disorders incl. 535 deaths
- 231 Pregnancy, puerperium and perinatal conditions incl. 9 deaths
- 83 Product issues
- 7,002 Psychiatric disorders incl. 81 deaths
- 1,143 Renal and urinary disorders incl. 82 deaths
- 1,241 Reproductive system and breast disorders incl. 2 deaths
- 16,257 Respiratory, thoracic and mediastinal disorders incl. 619 deaths
- 18,516 Skin and subcutaneous tissue disorders incl. 46 deaths
- 564 Social circumstances incl. 9 deaths
- 142 Surgical and medical procedures incl. 9 deaths
- 9,851 Vascular disorders incl. 197 deaths
Total reactions for the experimental mRNA vaccine mRNA-1273(CX-024414) from Moderna: 2,865 deaths and 22,985 injuries to 08/05/2021
- 1,047 Blood and lymphatic system disorders incl. 19 deaths
- 1,674 Cardiac disorders incl. 301 deaths
- 8 Congenital, familial and genetic disorders incl. 2 deaths
- 535 Ear and labyrinth disorders
- 29 Endocrine disorders incl. 1 death
- 793 Eye disorders incl. 4 deaths
- 4,952 Gastrointestinal disorders incl. 100 deaths
- 16,192 General disorders and administration site conditions incl. 1255 deaths
- 98 Hepatobiliary disorders incl. 6 deaths
- 587 Immune system disorders incl. 4 deaths
- 1,906 Infections and infestations incl. 151 deaths
- 1,042 Injury, poisoning and procedural complications incl. 53 deaths
- 1,395 Investigations incl. 68 deaths
- 670 Metabolism and nutrition disorders incl. 58 deaths
- 7,143 Musculoskeletal and connective tissue disorders incl. 58 deaths
- 60 Neoplasms benign, malignant and unspecified (incl cysts and polyps) incl. 11 deaths
- 9,617 Nervous system disorders incl. 294 deaths
- 62 Pregnancy, puerperium and perinatal conditions
- 11 Product issues
- 1,118 Psychiatric disorders incl. 45 deaths
- 383 Renal and urinary disorders incl. 32 deaths
- 135 Reproductive system and breast disorders incl. 1 death
- 2,822 Respiratory, thoracic and mediastinal disorders incl. 255 deaths
- 2,901 Skin and subcutaneous tissue disorders incl. 22 deaths
- 214 Social circumstances incl. 9 deaths
- 131 Surgical and medical procedures incl. 16 deaths
- 1,526 Vascular disorders incl. 100 deaths
Total reactions for the experimental vaccine AZD1222/VAXZEVRIA (CHADOX1 NCOV-19) from Oxford/ AstraZeneca: 2,102 deaths and 208,873 injuries to 08/05/2021
- 6,221 Blood and lymphatic system disorders incl. 86 deaths
- 8,504 Cardiac disorders incl. 261 deaths
- 83 Congenital, familial and genetic disorders incl. 2 deaths
- 5,774 Ear and labyrinth disorders
- 174 Endocrine disorders incl. 2 deaths
- 9,158 Eye disorders incl. 7 deaths
- 62,739 Gastrointestinal disorders incl. 99 deaths
- 158,518General disorders and administration site conditions incl. 604 deaths
- 319 Hepatobiliary disorders incl. 18 deaths
- 2,135 Immune system disorders incl. 8 deaths
- 12,002 Infections and infestations incl. 138 deaths
- 4,991 Injury, poisoning and procedural complications incl. 33 deaths
- 11,441 Investigations incl. 38 deaths
- 7,621 Metabolism and nutrition disorders incl. 31 deaths
- 93,094 Musculoskeletal and connective tissue disorders incl. 24 deaths
- 178 Neoplasms benign, malignant and unspecified (incl cysts and polyps) incl. 5 deaths
- 125,892Nervous system disorders incl. 318 deaths
- 128 Pregnancy, puerperium and perinatal conditions incl. 1 death
- 64 Product issues
- 10,895 Psychiatric disorders incl. 17 deaths
- 1,976 Renal and urinary disorders incl. 20 deaths
- 2,519 Reproductive system and breast disorders
- 18,411 Respiratory, thoracic and mediastinal disorders incl. 228 deaths
- 26,202 Skin and subcutaneous tissue disorders incl. 13 deaths
- 475 Social circumstances incl. 4 deaths
- 431 Surgical and medical procedures incl. 14 deaths
- 10,653 Vascular disorders incl. 131 deaths
Total reactions for the experimental COVID-19 vaccine JANSSEN (AD26.COV2.S) from Johnson & Johnson: 235 deaths and 2,873 injuries to 08/05/2021
- 79 Blood and lymphatic system disorders incl. 7 deaths
- 169 Cardiac disorders incl. 22 deaths
- 3 Congenital, familial and genetic disorders
- 45 Ear and labyrinth disorders
- 3 Endocrine disorders incl. 1 death
- 110 Eye disorders incl. 1 death
- 783 Gastrointestinal disorders incl. 6 deaths
- 2,071 General disorders and administration site conditions incl. 67 deaths
- 20 Hepatobiliary disorders incl. 1 death
- 35 Immune system disorders
- 140 Infections and infestations incl. 6 deaths
- 117 Injury, poisoning and procedural complications incl. 2 deaths
- 507 Investigations incl. 11 deaths
- 56 Metabolism and nutrition disorders incl. 6 deaths
- 1,348 Musculoskeletal and connective tissue disorders incl. 9 deaths
- 4 Neoplasms benign, malignant and unspecified (incl cysts and polyps)
- 1,852 Nervous system disorders incl. 32 deaths
- 5 Pregnancy, puerperium and perinatal conditions
- 4 Product issues
- 116 Psychiatric disorders incl. 2 deaths
- 35 Renal and urinary disorders incl. 3 deaths
- 29 Reproductive system and breast disorders
- 366 Respiratory, thoracic and mediastinal disorders incl. 18 deaths
- 172 Skin and subcutaneous tissue disorders incl. 1 death
- 20 Social circumstances incl. 1 death
- 80 Surgical and medical procedures incl. 10 deaths
- 502 Vascular disorders incl. 29 deaths